| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1000251426 |
| P356 | DOI | 10.1038/SJ.BMT.1703015 |
| P698 | PubMed publication ID | 11436099 |
| P2093 | author name string | Spitzer TR | |
| P2860 | cites work | Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patients | Q33499065 |
| Pathophysiologic mechanisms of acute graft-vs.-host disease | Q33793177 | ||
| Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome | Q40615300 | ||
| An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose | Q40624714 | ||
| Production of tumor necrosis factor alpha and interferon gamma in interleukin-2-treated melanoma patients: correlation with clinical toxicity | Q40754979 | ||
| Pulmonary hemorrhage as a cause of death in allogeneic bone marrow recipients with severe acute graft-versus-host disease. | Q40806099 | ||
| Outcome of recipients of bone marrow transplants who require intensive-care unit support | Q42609265 | ||
| Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies | Q43505338 | ||
| ICAM-1 expression on epidermal keratinocytes in cutaneous graft-versus-host disease. | Q43763941 | ||
| Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients | Q44067827 | ||
| Multiple organ dysfunction syndrome in bone marrow transplantation | Q44333474 | ||
| MISMATCHED FAMILY DONORS FOR BONE-MARROW TRANSPLANTATION AS TREATMENT FOR ACUTE LEUKAEMIA | Q60497057 | ||
| Regulation of Rransendothelial Neutrophil Migration by Endogenous Interleukin-8 | Q67701914 | ||
| Levels of the terminal complement complex, C3a-desArg and C1-inhibitor in adult patients with capillary leak syndrome following bone marrow transplantation | Q70819355 | ||
| Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation. University of Nebraska Medical Center Bone Marrow Transplant Group | Q72382472 | ||
| Outcome of patients requiring medical ICU admission following bone marrow transplantation | Q72852773 | ||
| Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy | Q73043658 | ||
| High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients | Q73072051 | ||
| Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administration | Q73446036 | ||
| Risk factors for capillary leakage syndrome after bone marrow transplantation | Q73454177 | ||
| C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation | Q73877807 | ||
| Successful management of adult respiratory distress syndrome (ARDS) after high-dose chemotherapy and peripheral blood progenitor cell rescue by non-invasive ventilatory support | Q74667668 | ||
| Engraftment syndrome and survival after respiratory failure post-bone marrow transplantation | Q77169287 | ||
| Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation | Q77810550 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | stem cell transplantation | Q65592366 |
| P304 | page(s) | 893-898 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Engraftment syndrome following hematopoietic stem cell transplantation | |
| P478 | volume | 27 |
| Q37276584 | A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children. |
| Q91838682 | A critical role of the Gas6-Mer axis in endothelial dysfunction contributing to TA-TMA associated with GVHD |
| Q44971633 | A rare case of interstitial pneumonitis after tandem high-dose melphalan conditioning and autologous stem cell transplantation in multiple myeloma |
| Q40400005 | Acute eosinophilic pneumonia is a non-infectious lung complication after allogeneic hematopoietic stem cell transplantation. |
| Q37930715 | Acute graft-versus-host disease following hematopoietic stem-cell transplantation |
| Q40306199 | Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis |
| Q38726036 | Acute kidney injury in HCT: an update |
| Q35083894 | Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. |
| Q92600857 | Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions |
| Q39006094 | Association between C-reactive protein levels in the first 1-3 days post-transplant and allogeneic immune reactions |
| Q37103103 | Association of serum interleukin-7 levels with the development of acute graft-versus-host disease |
| Q91254526 | Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation |
| Q42184785 | Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma without Cryopreservation |
| Q38072649 | Blood stem cell products: toward sustainable benchmarks for clinical translation |
| Q52934940 | Bullous pemphigoid after allogeneic hematopoietic stem cell transplantation. |
| Q81093837 | Cardiac complications after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab |
| Q48234079 | Case of engraftment syndrome appearing as scratch dermatitis. |
| Q46339227 | Chimerism in pediatric hematopoietic stem cell transplantation and its correlation with the clinical outcome |
| Q38637173 | Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation. |
| Q40536686 | Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation |
| Q50539928 | Clinical significance of hemophagocytosis in BM clot sections during the peri-engraftment period following allogeneic hematopoietic SCT. |
| Q84007987 | Colitis secondary to engraftment syndrome in a patient with autologous peripheral blood stem cell transplant |
| Q38079626 | Comparison of the diagnostic value of procalcitonin and C-reactive protein after hematopoietic stem cell transplantation: a systematic review and meta-analysis |
| Q47733733 | Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients |
| Q54253594 | Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation. |
| Q37853600 | Cutaneous graft-versus-host disease: rationales and treatment options |
| Q73163911 | Development of allergy post-bone marrow transplantation |
| Q50225125 | Dexamethasone palmitate for patients with engraftment syndrome is associated with favorable outcome for children with hematological malignancy |
| Q35560264 | Differentiation syndrome in promyelocytic leukemia: clinical presentation, pathogenesis and treatment. |
| Q39287510 | Early Onset Noninfectious Pulmonary Syndromes after Hematopoietic Cell Transplantation |
| Q95567275 | Early and Acute Complications and the Principles of HSCT Nursing Care |
| Q33379959 | Early complications following haematopoietic SCT in children |
| Q36264701 | Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach |
| Q96306763 | Engraftment Syndrome and Acute Graft-versus-Host Disease: A Meta-Analysis |
| Q39222708 | Engraftment syndrome after allogeneic hematopoietic cell transplantation in adults |
| Q34079430 | Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes. |
| Q43198285 | Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center |
| Q40564199 | Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF). |
| Q40522096 | Engraftment syndrome after autologous peripheral blood progenitor cell transplantation in pediatric patients: a prospective evaluation of risk factors and outcome. |
| Q79206227 | Engraftment syndrome after hematopoietic stem cell transplantation in multiple myeloma |
| Q40563612 | Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria |
| Q40574813 | Engraftment syndrome in children undergoing autologous peripheral blood progenitor cell transplantation. |
| Q40361644 | Engraftment syndrome, but not acute GVHD, younger age, CYP3A5 or MDR1 polymorphisms, increases tacrolimus clearance in pediatric hematopoietic SCT. |
| Q40588563 | Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis |
| Q38315390 | Engraftment syndrome: double-edged sword of hematopoietic cell transplants |
| Q44372685 | Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas |
| Q40108868 | Evaluation of engraftment syndrome in children following full-matched related donor hematopoietic stem cell transplantations |
| Q36328397 | Evaluation of pulmonary infiltrates in patients after stem cell transplantation |
| Q33393944 | Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation |
| Q44738226 | Fatal pulmonary thromboembolism after a second course of high-dose chemotherapy with autologous peripheral blood stem cell transplantation |
| Q40119879 | Favorable outcome to glucocorticoid therapy for engraftment syndrome in pediatric autologous hematopoietic cell transplant |
| Q40269737 | Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients |
| Q40059731 | Fever in Patients With Cancer |
| Q44897853 | Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases |
| Q33640791 | HLA-mismatched renal transplantation without maintenance immunosuppression |
| Q33383509 | Hemophagocytic syndrome after hematopoietic stem cell transplantation: a prospective observational study |
| Q40148308 | High incidence of engraftment syndrome after haploidentical allogeneic stem cell transplantation. |
| Q34237823 | High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis |
| Q49716209 | How I treat acute graft versus host disease |
| Q40541443 | How long after neutrophil recovery should myeloid growth factors be continued in autologous hematopoietic stem cell transplant recipients? |
| Q40298360 | Hyperacute graft-versus-host disease: histological assessment of skin biopsy specimens from 19 cases |
| Q38285644 | Imaging of complications from hematopoietic stem cell transplant |
| Q47636630 | Immune Tolerance, Xenografts, and Large-Animal Studies in Transplantation |
| Q27001243 | Immuno-intervention for the induction of transplantation tolerance through mixed chimerism |
| Q41199377 | Improved Outcomes of Hematopoietic Stem Cell Transplantation in Patients With Infantile Malignant Osteopetrosis Using Fludarabine-Based Conditioning. |
| Q89891758 | Incidence and Mortality of Acute Kidney Injury in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-analysis |
| Q38175306 | Induction of tolerance through mixed chimerism |
| Q38096877 | Inflammatory markers in patients after hematopoietic stem cell transplantation |
| Q88506851 | Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation |
| Q90357548 | Late-onset fever and engraftment syndrome following autologous stem cell transplant: Impact on resource utilization |
| Q34496604 | Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. |
| Q91945665 | MBI-LCBI and CLABSI: more than scrubbing the line |
| Q36406434 | Macrophage activation syndrome and other systemic inflammatory conditions after BMT. |
| Q63815460 | Monocyte-predominant engraftment, cytokine levels and early transplant-related complications in pediatric hematopoietic stem cell recipients |
| Q43730168 | Neurologic Complications of Bone Marrow and Stem-cell Transplantation in Patients with Cancer. |
| Q33712196 | Non-infectious pulmonary complications after the hematopoietic stem cell transplantation |
| Q38285559 | Non-infectious respiratory disease in non-HIV immunocompromised patients. |
| Q44482347 | Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants |
| Q34637605 | One-unit versus two-unit cord-blood transplantation for hematologic cancers |
| Q80657401 | Origin of macrophages involved in the development of allogeneic hematopoietic stem cell transplantation-associated hemophagocytic syndrome: observations on a patient with juvenile myelomonocytic leukemia |
| Q51779327 | Outcome and treatment of late-onset noninfectious pulmonary complications after allogeneic haematopoietic SCT. |
| Q35547759 | Peri-engraftment clinical abnormalities following allogeneic hematopoietic cell transplantation: a retrospective review of 216 patients |
| Q40273597 | Peri-engraftment syndrome in allogeneic hematopoietic SCT. |
| Q45054605 | Pericarditis occurring with engraftment syndrome in a thalassemic patient |
| Q36575315 | Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome |
| Q83885727 | Post-autologous hematopoietic SCT engraftment syndrome: a single center experience |
| Q26852474 | Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation |
| Q39748070 | Pre-engraftment graft-versus-host disease after allogeneic hematopoietic cell transplantation for acute leukemia |
| Q34985679 | Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease |
| Q36983064 | Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment |
| Q40311559 | Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies |
| Q35149926 | Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism |
| Q104064700 | Prior anti-PD-1 therapy as a risk factor for life-threatening peri-engraftment respiratory distress syndrome in patients undergoing autologous stem cell transplantation |
| Q39268265 | Procalcitonin and cytokine profiles in engraftment syndrome in pediatric stem cell transplantation |
| Q90484595 | Procalcitonin as a biomarker to differentiate bacterial infections from engraftment syndrome following autologous hematopoietic stem cell transplantation for multiple myeloma |
| Q99730640 | Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation |
| Q90496982 | Pulmonary Infections in Immunocompromised Hosts: Clinical |
| Q42204784 | Pulmonary complications in hematopoietic SCT: a prospective study. |
| Q38215237 | Pulmonary complications of childhood cancers |
| Q35740698 | Pulmonary complications of solid organ and hematopoietic stem cell transplantation |
| Q33944909 | Pulmonary manifestations of the pre-engraftment syndrome after umbilical cord blood transplantation |
| Q88104111 | RETRACTED ARTICLE: DNA profiling in blood, buccal swabs, and hair follicles of transplantation patients |
| Q84526794 | Recombinant human soluble thrombomodulin counteracts capillary leakage associated with engraftment syndrome |
| Q40386808 | Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma. |
| Q97881676 | Severe, Reversible Acute Lung Injury During Autologous Hematopoietic Stem Cell Mobilization After Filgrastim in a Child With Neuroblastoma: A Case Report |
| Q38129306 | Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children |
| Q36729785 | Stem cell myths |
| Q40517545 | Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection |
| Q38687525 | Sublethal heat shock induces premature senescence rather than apoptosis in human mesenchymal stem cells. |
| Q40347834 | Syngeneic Donor Hematopoietic Stem Cell Transplantation Is Associated with High Rates of Engraftment Syndrome |
| Q57285216 | The Diagnostic Yield, Safety, and Impact of Flexible Bronchoscopy in Non-HIV Immunocompromised Critically Ill Patients in the Intensive Care Unit |
| Q47670674 | The Rare Complication and Diagnostic Challenges of Pulmonary Eosinophilia in Graft versus Host Disease Patients after Hematopoietic Stem Cell Transplantation |
| Q33760834 | The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantation |
| Q40295927 | The clinical role of procalcitonin in hematopoietic SCT. |
| Q40474709 | The clinical value of biomarkers in respiratory complications in hematopoietic SCT. |
| Q38274890 | The double-edged sword: Neurotoxicity of chemotherapy |
| Q94671653 | The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium |
| Q36707835 | The lung function score and its components as predictors of overall survival and chronic graft-vs-host disease after allogeneic stem cell transplantation |
| Q38514485 | The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT. |
| Q37796528 | The spectrum of noninfectious pulmonary complications following hematopoietic stem cell transplantation |
| Q34082059 | Transplantation tolerance: from theory to clinic |
| Q37037513 | Veno-occlusive disease in a child with rhabdomyosarcoma after conventional chemotherapy: report of a case and review of the literature |
| Q30251535 | Venous thromboembolism following hematopoietic stem cell transplantation-a systematic review and meta-analysis |
| Q40361692 | Viral encephalitis after haplo-identical hematopoietic stem cell transplantation: Causative viral spectrum, characteristics, and risk factors. |
Search more.